Frank J. Lane
Director/Miembro de la Junta en ALBERT LABS INTERNATIONAL CORP. .
Perfil
Frank J.
Lane is the founder of Cfn Media, which was founded in 2013, where he holds the title of President.
Currently, he holds the position of Director at Albert Labs, Inc. and Albert Labs International Corp.
Additionally, he is the President & Executive Officer-CFN Media at CFN Enterprises, Inc. since 2019.
Mr. Lane received his undergraduate degree from Seattle University in 1989.
Cargos activos de Frank J. Lane
| Empresas | Cargo | Inicio |
|---|---|---|
| CFN ENTERPRISES INC. | Corporate Officer/Principal | 01/06/2019 |
| ALBERT LABS INTERNATIONAL CORP. | Director/Miembro de la Junta | - |
| Cfn Media | Fundador | 01/01/2013 |
Albert Labs, Inc.
 Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Director/Miembro de la Junta | - |
Formación de Frank J. Lane.
| Seattle University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CFN ENTERPRISES INC. | Technology Services |
| ALBERT LABS INTERNATIONAL CORP. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| Cfn Media | |
Albert Labs, Inc.
Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Health Services |
- Bolsa de valores
- Insiders
- Frank J. Lane
